title: Preface to the special issue "Novel pharmaconeurogenetic approaches arising from progress in translational genetics".
authors.affiliation: Neuroscience, Merck Research Laboratories, Sumneytown Pike, West Point, PA 19486, USA. john_renger@merck.com
authors.forename: John J
authors.initials: JJ
authors.lastname: Renger
authors.forename: Jonathan T
authors.initials: JT
authors.lastname: Kern
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical / Q000379:methods / Q000639:trends; D004345:Drug Industry / Q000379:methods / Q000639:trends*; D006801:Humans; D008967:Molecular Biology / Q000379:methods / Q000639:trends*; D009422:Nervous System Diseases / Q000188:drug therapy* / Q000235:genetics*; D009480:Neuropharmacology / Q000379:methods / Q000639:trends*; D057170:Translational Research, Biomedical / Q000379:methods / Q000639:trends*